Location: Larkspur, CA
CIK: 0001425738 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 15, 2017
Total Value: $1.541B (99.2% shares, 0.8% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 12,765,862 | $114M | 7.4% | $4.81 | — | COM | 04269X105 |
| PEN | PENUMBRA INC | 1,034,408 | $86.32M | 5.6% | $49.77 | +52.1% | COM | 70975L107 |
| FOLD | AMICUS THERAPEUTICS INC | 11,375,852 | $81.11M | 5.3% | $7.13 | -11.4% | COM | 03152W109 |
| PBYI | PUMA BIOTECHNOLOGY INC | 1,725,414 | $64.19M | 4.2% | $44.35 | -17.7% | COM | 74587V107 |
| — | CLOVIS ONCOLOGY INC | 972,696 | $61.93M | 4.0% | $34.31 | — | COM | 189464100 |
| — | ATARA BIOTHERAPEUTICS INC | 2,734,118 | $56.19M | 3.6% | $23.48 | — | COM | 046513107 |
| AGIO | AGIOS PHARMACEUTICALS INC | 902,578 | $52.71M | 3.4% | $44.35 | +8.1% | COM | 00847X104 |
| MOH | MOLINA HEALTHCARE INC | 1,149,727 | $52.43M | 3.4% | $54.71 | -4.3% | COM | 60855R100 |
| PRTA | PROTHENA CORP PLC | 849,483 | $47.39M | 3.1% | $48.00 | +9.5% | SHS | G72800108 |
| — | SEATTLE GENETICS INC | 696,386 | $43.77M | 2.8% | $41.29 | — | COM | 812578102 |
| INCY | INCYTE CORP | 307,723 | $41.13M | 2.7% | $92.56 | +37.5% | COM | 45337C102 |
| — | GW PHARMACEUTICALS PLC | 332,544 | $40.22M | 2.6% | $132.73 | — | ADS | 36197T103 |
| — | ALDER BIOPHARMACEUTICALS INC | 1,909,886 | $39.73M | 2.6% | $25.20 | — | COM | 014339105 |
| XNCR | XENCOR INC | 1,592,526 | $38.09M | 2.5% | $24.07 | +0.1% | COM | 98401F105 |
| WVE | WAVE LIFE SCIENCES LTD | 1,271,097 | $34.95M | 2.3% | $22.05 | +26.7% | SHS | Y95308105 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 934,343 | $34.43M | 2.2% | $29.26 | — | COM | 37890U108 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 2,004,849 | $31.05M | 2.0% | $14.31 | — | ORD SHS | G6855A103 |
| BSX | BOSTON SCIENTIFIC CORP | 1,200,099 | $29.85M | 1.9% | $21.87 | +11.2% | COM | 101137107 |
| — | INC RESH HLDGS INC | 633,779 | $29.06M | 1.9% | $45.85 | — | CL A | 45329R109 |
| ELV | ANTHEM INC | 175,328 | $29M | 1.9% | $131.37 | +7.7% | COM | 036752103 |
| — | CHIMERIX INC | 4,325,055 | $27.59M | 1.8% | $4.50 | — | COM | 16934W106 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 622,345 | $26.95M | 1.7% | $42.84 | 0.0% | COM | 64125C109 |
| — | NEURODERM LTD | 924,304 | $24.54M | 1.6% | $21.26 | — | ORD SHS | M74231107 |
| ICUI | ICU MED INC | 160,543 | $24.52M | 1.6% | $146.16 | 0.0% | COM | 44930G107 |
| RGNX | REGENXBIO INC | 1,269,131 | $24.49M | 1.6% | $19.29 | 0.0% | COM | 75901B107 |
| — | JOUNCE THERAPEUTICS INC | 1,114,160 | $22.52M | 1.5% | $20.22 | — | COM | 481116101 |
| — | IMMUNOMEDICS INC | 3,380,846 | $21.87M | 1.4% | $6.47 | — | COM | 452907108 |
| — | PATHEON N V | 826,843 | $21.78M | 1.4% | $27.60 | — | SHS | N6865W105 |
| — | DIPLOMAT PHARMACY INC | 1,254,342 | $20.01M | 1.3% | $15.54 | — | COM | 25456K101 |
| — | ENDOLOGIX INC | 2,717,394 | $19.67M | 1.3% | $8.60 | — | COM | 29266S106 |
| — | EXPRESS SCRIPTS HLDG CO | 293,807 | $19.36M | 1.3% | $68.79 | — | COM | 30219G108 |
| — | NANOSTRING TECHNOLOGIES INC | 934,424 | $18.57M | 1.2% | $13.81 | — | COM | 63009R109 |
| — | LA JOLLA PHARMACEUTICAL CO | 604,470 | $18.04M | 1.2% | $29.85 | — | COM PAR $.0001 2 | 503459604 |
| — | CATALENT INC | 624,000 | $17.67M | 1.1% | $28.32 | — | COM | 148806102 |
| — | CASCADIAN THERAPEUTICS INC | 4,072,424 | $16.86M | 1.1% | $4.14 | — | COM NEW | 14740B606 |
| — | PAREXEL INTL CORP | 260,231 | $16.42M | 1.1% | $63.11 | — | COM | 699462107 |
| — | SPECTRANETICS CORP | 557,189 | $16.23M | 1.1% | $25.62 | — | COM | 84760C107 |
| — | BLUEPRINT MEDICINES CORP | 400,000 | $16M | 1.0% | $39.99 | — | COM | 09627Y109 |
| — | IMMUNOGEN INC | 3,984,734 | $15.42M | 1.0% | $3.87 | — | COM | 45253H101 |
| — | SYROS PHARMACEUTICALS INC | 952,740 | $15.18M | 1.0% | $15.69 | — | COM | 87184Q107 |
| EHTH | EHEALTH INC | 1,191,334 | $14.34M | 0.9% | $10.43 | +10.9% | COM | 28238P109 |
| — | AUDENTES THERAPEUTICS INC | 820,836 | $13.99M | 0.9% | $16.26 | — | COM | 05070R104 |
| — | ARRAY BIOPHARMA INC | 9,000,000 | $12.76M | 0.8% | $1.26 | — | NOTE 3.000% 6/0 | 04269XAA3 |
| CTMX | CYTOMX THERAPEUTICS INC | 681,892 | $11.78M | 0.8% | $15.82 | -16.8% | COM | 23284F105 |
| MCK | MCKESSON CORP | 78,300 | $11.61M | 0.8% | $136.52 | 0.0% | COM | 58155Q103 |
| CRL | CHARLES RIV LABS INTL INC | 121,307 | $10.91M | 0.7% | $74.85 | +13.5% | COM | 159864107 |
| — | INVITAE CORP | 812,240 | $8.983M | 0.6% | $8.48 | — | COM | 46185L103 |
| — | MODEL N INC | 822,314 | $8.593M | 0.6% | $10.67 | — | COM | 607525102 |
| PRQR | PROQR THRAPEUTICS N V | 1,553,225 | $7.766M | 0.5% | $8.98 | -51.0% | SHS EURO | N71542109 |
| FATE | FATE THERAPEUTICS INC | 1,419,058 | $6.457M | 0.4% | $5.74 | -36.3% | COM | 31189P102 |
| — | DYNAVAX TECHNOLOGIES CORP | 1,019,491 | $6.066M | 0.4% | $3.95 | — | COM NEW | 268158201 |
| SGRY | SURGERY PARTNERS INC | 303,500 | $5.918M | 0.4% | $19.43 | 0.0% | COM | 86881A100 |
| — | AVEXIS INC | 45,349 | $3.448M | 0.2% | $76.03 | — | COM | 05366U100 |
| ACRS | ACLARIS THERAPEUTICS INC | 90,700 | $2.705M | 0.2% | $25.50 | +13.1% | COM | 00461U105 |
| — | RA PHARMACEUTICALS INC | 110,769 | $2.358M | 0.2% | $15.19 | — | COM | 74933V108 |
| AUPH | AURINIA PHARMACEUTICALS INC | 140,243 | $1.029M | 0.1% | $4.12 | +12.2% | COM | 05156V102 |
| UNH | UNITEDHEALTH GROUP INC | 1,820 | $298K | 0.0% | $120.51 | +17.9% | COM | 91324P102 |
| — | AMEDISYS INC | 4,826 | $247K | 0.0% | $51.18 | — | COM | 023436108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 22,236 | $60,000 | 0.0% | $3.15 | — | COM | 00773U108 |
| — | CASTLIGHT HEALTH INC | 10,229 | $37,000 | 0.0% | $4.01 | — | CL B | 14862Q100 |